| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. | Director | Common Stock | 4.18K | $13.2K | $3.16 | Nov 21, 2025 | Direct |
| Inhibitor Therapeutics, Inc. | Director | Common Stock | 80.4K | Apr 1, 2025 | Direct | ||
| MIRA PHARMACEUTICALS, INC. | Director | Nonqualified Stock Option (right to buy) | 25K | Mar 25, 2024 | Direct | ||
| Telomir Pharmaceuticals, Inc. | Director | Incentive Stock Options (right to buy) | 25K | Aug 27, 2024 | Direct | ||
| Alaunos Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 3.2K | Jul 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics, Inc. | Nov 21, 2025 | 1 | $13.2K | 4 | Nov 26, 2025 | Director |
| TCRT | Alaunos Therapeutics, Inc. | Jul 15, 2025 | 2 | $0 | 4 | Jul 17, 2025 | Director |
| TCRT | Alaunos Therapeutics, Inc. | Jul 15, 2025 | 0 | $0 | 3 | Jul 17, 2025 | Director |
| TELO | Telomir Pharmaceuticals, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Aug 29, 2024 | Director |
| INTI | Inhibitor Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 7, 2025 | Director |
| INTI | Inhibitor Therapeutics, Inc. | Apr 1, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
| MIRA | MIRA PHARMACEUTICALS, INC. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Director |
| TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | Director |
| MIRA | MIRA PHARMACEUTICALS, INC. | Nov 14, 2023 | 0 | $0 | 3 | Nov 20, 2023 | Director |